Molecular Targets in Alzheimer's Disease

被引:25
|
作者
Bjorklund, Geir [1 ]
Aaseth, Jan [2 ,3 ]
Dadar, Maryam [4 ]
Chirumbolo, Salvatore [5 ]
机构
[1] Council Nutr & Environm Med, Toften 24, N-8610 Mo I Rana, Norway
[2] Inland Norway Univ Appl Sci, Fac Hlth & Social Sci, Elverum, Norway
[3] Innlandet Hosp Trust, Dept Res, Brumunddal, Norway
[4] Razi Vaccine & Serum Res Inst, AREEO, Karaj, Iran
[5] Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy
关键词
Alzheimer's disease; Amyloid beta; Tau protein; Oxidative stress; AMYLOID-BETA-PEPTIDE; PROTEIN-TYROSINE PHOSPHATASES; MITOCHONDRIAL TRANSFER-RNAS; HUMAN PRESEQUENCE PROTEASE; CHYMOTRYPSIN-LIKE ACTIVITY; NITRIC-OXIDE SYNTHASE; OXIDATIVE STRESS; 20S PROTEASOME; REVERSIBLE INACTIVATION; BRAIN MITOCHONDRIA;
D O I
10.1007/s12035-019-1563-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alzheimer's disease (AD) is known as a devastating neurodegenerative disorder in aged subjects, which is related to multiple heterogeneous genetic factors. The two basic pathological aspects of AD are related to amyloid beta (A beta) peptides and tau proteins. Some researchers have demonstrated plaques and tangles as apparently primary lesions. Also, experimental data propose that these two lesions are intimately related. In the present review, we highlight some molecular mechanisms linking tau and A beta toxicities involving oxidative stress, aging, A beta turnover, the contribution of thiol groups, and the role mitochondrial activities in the AD pathogenesis. Understanding the interplay of these mechanisms as parts of common pathophysiological pathways could reveal molecular targets to control or even treat AD.
引用
收藏
页码:7032 / 7044
页数:13
相关论文
共 50 条
  • [41] Potential Alzheimer's disease targets identified
    不详
    [J]. FUTURE MEDICINAL CHEMISTRY, 2009, 1 (02) : 239 - 239
  • [42] Peptides as drug targets for Alzheimer's disease
    Gozes, I
    Spier, AD
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 229 : 344 - 344
  • [43] MicroRNAs as Therapeutic Targets for Alzheimer's Disease
    Di Meco, Antonio
    Pratico, Domenico
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2016, 53 (02) : 367 - 372
  • [44] Secretases as targets for the treatment of Alzheimer's disease
    Citron, M
    [J]. MOLECULAR MEDICINE TODAY, 2000, 6 (10): : 392 - 397
  • [45] Phosphodiesterases as Therapeutic Targets for Alzheimer's Disease
    Garcia-Osta, Ana
    Cuadrado-Tejedor, Mar
    Garcia-Barroso, Carolina
    Oyarzabal, Julen
    Franco, Rafael
    [J]. ACS CHEMICAL NEUROSCIENCE, 2012, 3 (11): : 832 - 844
  • [46] Inflammasomes as therapeutic targets for Alzheimer's disease
    White, Claire S.
    Lawrence, Catherine B.
    Brough, David
    Rivers-Auty, Jack
    [J]. BRAIN PATHOLOGY, 2017, 27 (02) : 223 - 234
  • [47] Multiple Targets for the Management of Alzheimer's Disease
    Ahmad, Syed Sayeed
    Akhtar, Salman
    Jamal, Qazi Mohammad Sajid
    Rizvi, Syed Mohd. Danish
    Kamal, Mohammad A.
    Khan, M. Kalim A.
    Siddiqui, Mohd. Haris
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2016, 15 (10) : 1279 - 1289
  • [48] Challenges and Future Prospects: A Benefaction of Phytoconstituents on Molecular Targets Pertaining to Alzheimer's Disease
    Sharma, Himanshu
    Chandra, Phool
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2024, 14 (01)
  • [49] A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease
    Lahiri, DK
    Farlow, MR
    Sambamurti, K
    Greig, NH
    Giacobini, E
    Schneider, LS
    [J]. CURRENT DRUG TARGETS, 2003, 4 (02) : 97 - 112
  • [50] Current Status of Alzheimer's Disease and Pathological Mechanisms Investigating the Therapeutic Molecular Targets
    Bagga, Shivani
    Kumar, Manish
    [J]. CURRENT MOLECULAR MEDICINE, 2023, 23 (06) : 492 - 508